AR229350A1 - Procedimiento para la preparacion de nuevas guanilamidinas - Google Patents

Procedimiento para la preparacion de nuevas guanilamidinas

Info

Publication number
AR229350A1
AR229350A1 AR284300A AR28430081A AR229350A1 AR 229350 A1 AR229350 A1 AR 229350A1 AR 284300 A AR284300 A AR 284300A AR 28430081 A AR28430081 A AR 28430081A AR 229350 A1 AR229350 A1 AR 229350A1
Authority
AR
Argentina
Prior art keywords
guanilamidinas
procedure
preparation
new
new guanilamidinas
Prior art date
Application number
AR284300A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR229350A1 publication Critical patent/AR229350A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR284300A 1980-02-19 1981-02-16 Procedimiento para la preparacion de nuevas guanilamidinas AR229350A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/122,155 US4269837A (en) 1980-02-19 1980-02-19 Hypoglycemic guanylamidines, compositions and use

Publications (1)

Publication Number Publication Date
AR229350A1 true AR229350A1 (es) 1983-07-29

Family

ID=22401029

Family Applications (1)

Application Number Title Priority Date Filing Date
AR284300A AR229350A1 (es) 1980-02-19 1981-02-16 Procedimiento para la preparacion de nuevas guanilamidinas

Country Status (18)

Country Link
US (1) US4269837A (OSRAM)
EP (1) EP0034495B1 (OSRAM)
JP (1) JPS56147760A (OSRAM)
KR (1) KR840000930B1 (OSRAM)
AR (1) AR229350A1 (OSRAM)
AT (1) ATE3425T1 (OSRAM)
AU (1) AU517843B2 (OSRAM)
CA (1) CA1145334A (OSRAM)
DE (1) DE3160290D1 (OSRAM)
DK (1) DK70881A (OSRAM)
ES (1) ES499572A0 (OSRAM)
FI (1) FI75343C (OSRAM)
GR (1) GR78339B (OSRAM)
IE (1) IE50924B1 (OSRAM)
IL (1) IL62146A (OSRAM)
PH (1) PH15971A (OSRAM)
PT (1) PT72516B (OSRAM)
YU (1) YU41968B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404219A (en) * 1980-03-31 1983-09-13 Pfizer Inc. Phenylguanidine therapeutic agents
US5268373A (en) * 1992-07-28 1993-12-07 Mcneilab, Inc. Guanidine derivatives, compositions and use
ES2164990T3 (es) * 1996-04-30 2002-03-01 Pfizer Agonistas de receptores muscarinicos.
AR008290A1 (es) * 1996-08-15 1999-12-29 Smithkline Beecham Corp Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH478802A (de) 1966-09-06 1969-09-30 Sandoz Ag Verfahren zur Herstellung von Pyrazolderivaten
CS225804B2 (cs) 1976-03-19 1984-02-13 Mcneilab Inc Způsob výroby heterocyklických derivátů guanidinu

Also Published As

Publication number Publication date
PT72516A (en) 1981-03-01
PT72516B (en) 1982-10-21
IL62146A (en) 1984-09-30
DE3160290D1 (en) 1983-07-07
PH15971A (en) 1983-05-11
CA1145334A (en) 1983-04-26
IL62146A0 (en) 1981-03-31
ES8201541A1 (es) 1981-12-16
YU39881A (en) 1983-09-30
FI75343C (fi) 1988-06-09
ES499572A0 (es) 1981-12-16
KR840000930B1 (ko) 1984-06-29
KR830005188A (ko) 1983-08-03
ATE3425T1 (de) 1983-06-15
IE810311L (en) 1981-08-19
YU41968B (en) 1988-04-30
EP0034495B1 (en) 1983-05-18
US4269837A (en) 1981-05-26
JPS6348265B2 (OSRAM) 1988-09-28
FI810492L (fi) 1981-08-20
DK70881A (da) 1981-08-20
JPS56147760A (en) 1981-11-16
IE50924B1 (en) 1986-08-20
AU517843B2 (en) 1981-08-27
FI75343B (fi) 1988-02-29
EP0034495A3 (en) 1982-01-27
EP0034495A2 (en) 1981-08-26
GR78339B (OSRAM) 1984-09-26

Similar Documents

Publication Publication Date Title
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
MX6802E (es) Procedimiento para la preparacion de derivados carboestirilicos
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
ES507635A0 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
ES501535A0 (es) Procedimiento para la preparacion de derivados de alquilfos-fonito
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES503407A0 (es) Procedimiento para la preparacion de derivados de pirimidina
ES499729A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol
ES526538A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES502120A0 (es) Procedimiento para la preparacion de compuestos de viniles- tilbeno
ES501736A0 (es) Procedimiento para la preparacion de derivados de 2-guanidi-notiazol
ES502649A0 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos
ES500068A0 (es) Procedimiento para la obtencion de nuevos tioles
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
ES505095A0 (es) Procedimiento para la preparacion de nuevas pirazinas
ES505576A0 (es) Procedimiento para la preparacion de derivados de 7-oxopros-taciclina
MX6707E (es) Procedimiento para la preparacion de n(1-alil-2-pirrolidinilmetil)-2-metoxi-4-amino-5-metil-sulfamoil-benzamida
ES499356A0 (es) Procedimiento para la preparacion de derivados de rifamicina
ES499209A0 (es) Procedimiento para la preparacion de 3-desoxi-a15-esteroides
ES505324A0 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas